Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
These findings suggest an increased risk for NRM, particularly infection-related deaths, associated with C1-inferior donors. Upon independent confirmation, C1-inferior donors should be avoided in PTCy-based haploidentical HSCT.
Authors
- Alexander Nikoloudis (ORCID: https://orcid.org/0000-0001-5713-6257)
- Thomas Bauer (ORCID: https://orcid.org/0000-0003-4080-7944)
- Olga Stiefel
- Sigrid Machherndl‐Spandl (ORCID: https://orcid.org/0009-0007-1247-7948)
- Christoph Aichinger
- Andreas Petzer (ORCID: https://orcid.org/0000-0003-1595-0300)
- Emine Kaynak (ORCID: https://orcid.org/0000-0001-9850-2532)
- Holger F. Rumpold (ORCID: https://orcid.org/0000-0002-4118-0111)
- Veronika Buxhofer‐Ausch (ORCID: https://orcid.org/0000-0002-7369-9700)
- Robert Milanov
- Irene Straßl (ORCID: https://orcid.org/0000-0001-9649-5850)
- Johannes Clausen (ORCID: https://orcid.org/0000-0002-2729-9706)
- Dagmar Wipplinger
- Ansgar Weltermann
- Petra Hasengruber
- Michaela Binder
- Anna Bauhofer (ORCID: https://orcid.org/0000-0003-2943-4614)
- Lena Griessl
- Anke Habermehl
- Christina Groiss
Institutions
- Krankenhaus der Elisabethinen (AT)
Publication Details
- Journal
- Cytotherapy
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1016/j.jcyt.2024.12.003
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00